Yusuke Tanigawara

10.4k total citations · 3 hit papers
177 papers, 8.8k citations indexed

About

Yusuke Tanigawara is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Yusuke Tanigawara has authored 177 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 54 papers in Molecular Biology and 36 papers in Pharmacology. Recurrent topics in Yusuke Tanigawara's work include Drug Transport and Resistance Mechanisms (42 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Pharmacogenetics and Drug Metabolism (24 papers). Yusuke Tanigawara is often cited by papers focused on Drug Transport and Resistance Mechanisms (42 papers), Antibiotics Pharmacokinetics and Efficacy (31 papers) and Pharmacogenetics and Drug Metabolism (24 papers). Yusuke Tanigawara collaborates with scholars based in Japan, New Zealand and United States. Yusuke Tanigawara's co-authors include Terumichi Nakagawa, Kiyoshi Yamaoka, Toyozo Uno, Kazumitsu Ueda, Tohru Komano, R Hori, Takashi Saeki, Noboru Okamura, Midori Hirai and Noriyuki Kioka and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Yusuke Tanigawara

173 papers receiving 8.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pharmacokinetic analysis program (multi) for microcomputer.

1981 2.3k citations Yusuke Tanigawara et al. profile →
Human P-glycoprotein transports cyclosporin A and FK506.

1993 597 citations Yusuke Tanigawara, R Hori et al. profile →
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

1992 578 citations Yusuke Tanigawara et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yusuke Tanigawara Japan	40	3.9k	2.1k	1.9k	1.5k	1.4k	177	8.8k
Toshiyuki Sakaeda Japan	45	2.8k 0.7×	2.1k 1.0×	1.4k 0.7×	974 0.7×	727 0.5×	220	7.1k
Jiunn H. Lin United States	50	3.9k 1.0×	2.0k 0.9×	1.4k 0.7×	3.1k 2.1×	938 0.7×	126	8.7k
Dirk K. F. Meijer Netherlands	54	4.2k 1.1×	2.8k 1.3×	1.9k 1.0×	1.6k 1.1×	751 0.6×	282	10.5k
Heyo K. Kroemer Germany	57	4.2k 1.1×	2.4k 1.2×	2.1k 1.1×	1.5k 1.0×	619 0.5×	180	9.8k
Hilde Rosing Netherlands	56	6.7k 1.7×	4.6k 2.2×	1.5k 0.8×	1.6k 1.1×	1.2k 0.9×	422	13.3k
Jashvant D. Unadkat United States	67	5.5k 1.4×	2.2k 1.0×	3.8k 2.0×	2.7k 1.8×	1.1k 0.8×	309	12.5k
Werner Siegmund Germany	42	2.7k 0.7×	1.1k 0.5×	1.5k 0.8×	1.0k 0.7×	560 0.4×	185	6.3k
Katsuhiko Okumura Japan	39	2.3k 0.6×	1.4k 0.7×	1.3k 0.7×	874 0.6×	635 0.5×	179	5.2k
Kim L. R. Brouwer United States	55	6.0k 1.6×	1.4k 0.7×	3.2k 1.7×	3.4k 2.3×	839 0.6×	279	9.7k
Alwin D. R. Huitema Netherlands	56	4.3k 1.1×	2.9k 1.4×	1.5k 0.8×	1.2k 0.8×	764 0.6×	552	12.9k

Countries citing papers authored by Yusuke Tanigawara

Since Specialization

Citations

This map shows the geographic impact of Yusuke Tanigawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Tanigawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Tanigawara more than expected).

Fields of papers citing papers by Yusuke Tanigawara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Tanigawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Tanigawara. The network helps show where Yusuke Tanigawara may publish in the future.

Co-authorship network of co-authors of Yusuke Tanigawara

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Tanigawara. A scholar is included among the top collaborators of Yusuke Tanigawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Tanigawara. Yusuke Tanigawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otani, Yuki, Richard Labotka, Mark Rogge, et al.. (2024). Modeling serum M‐protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone. CPT Pharmacometrics & Systems Pharmacology. 13(12). 2124–2136.

Booka, Eisuke, Chiyo K. Imamura, Masashi Takeuchi, et al.. (2022). Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials. Gastric Cancer. 25(4). 770–782. 1 indexed citations

Kenmotsu, Hirotsugu, Chiyo K. Imamura, Takahisa Kawamura, et al.. (2022). Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology. 90(2). 115–123. 3 indexed citations

Takeuchi, Masashi, Chiyo K. Imamura, Eisuke Booka, et al.. (2020). Prospective evaluation and refinement of an S‐1 dosage formula based on renal function for clinical application. Cancer Science. 112(2). 751–759. 3 indexed citations

Tsushima, Takahiro, Hidefumi Kasai, & Yusuke Tanigawara. (2020). Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer. Cancer Chemotherapy and Pharmacology. 86(4). 487–495. 3 indexed citations

Kawamura, Takahisa, et al.. (2018). Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data. Cancer Science. 109(9). 2822–2829. 6 indexed citations

Kasai, Hidefumi, et al.. (2018). Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker. Osteoporosis International. 29(5). 1155–1163. 15 indexed citations

Imamura, Chiyo K., et al.. (2017). Effect of everolimus on the glucose metabolic pathway in mouse skeletal muscle cells (C2C12). Metabolomics. 13(8). 98–98. 11 indexed citations

Terao, Kimio, Takehiko Kawanishi, Masataka Shiraki, et al.. (2011). Pharmacokinetics of eldecalcitol in primary osteoporosis patients - Randomized, double-blind, multicentre, long-term phase III clinical study. 39(3). 299–307. 4 indexed citations

10.

Takahashi, Fumiaki, et al.. (2011). Overview of the clinical pharmacokinetics of eldecalcitol, a new active vitamin D3 derivative. 39(3). 261–274. 13 indexed citations

11.

Takesue, Yoshio, Yusuke Tanigawara, Hiroshige Mikamo, et al.. (2010). Therapeutic drug monitoring survey of anti-MRSA agents in Japan. 58(2). 119–124. 4 indexed citations

12.

Tanigawara, Yusuke, Takako Shimizu, & Kyoichi Totsuka. (2009). Population pharmacokinetics and pharmacodynamics of 500 mg oral dose levofloxacin in respiratory tract infection patients. 57. 47–54. 4 indexed citations

13.

Asano, Koichiro, Tetsuya Shiomi, Takeshi Nakajima, et al.. (2009). Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics. Respirology. 14(6). 822–827. 8 indexed citations

14.

Miyata, Kôji, et al.. (2005). Population Pharmacokinetics of Faropenem in Healthy Human Volunteers and Patients. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 36(4). 197–207. 2 indexed citations

15.

Udaka, Toru, Chiharu Torii, Daisuke Takahashi, et al.. (2005). Comprehensive Screening of the Thiopurine Methyltransferase Polymorphisms by Denaturing High-Performance Liquid Chromatography. Genetic Testing. 9(2). 85–92. 7 indexed citations

16.

Sato, Reiko, et al.. (2005). Population pharmacokinetics (PK) and pharmacodynamics (PD) of arbekacin in patients infected with methicillin-resistant Staphylococcus aureus (MRSA). The Keio Journal of Medicine. 54(1). 41.

17.

Ku, You Jin, Yusuke Tanigawara, Ichiro Maeda, et al.. (1996). [Evaluation of concomitant use of cyclosporin and percutaneous isolated liver perfusion under complete venous isolation and charcoal hemoperfusion].. PubMed. 23(11). 1408–11. 1 indexed citations

18.

Nishiguchi, Kohshi, et al.. (1996). Effects of Transfection with the Cu, Zn-Superoxide Dismutase Gene on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Fibroblasts from Rat Skin. Pharmaceutical Research. 13(4). 577–582. 2 indexed citations

19.

Hori, R, et al.. (1992). Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.. Drug Metabolism and Disposition. 20(4). 541–546. 4 indexed citations

20.

Tanigawara, Yusuke, et al.. (1991). Pulmonary and hepatic disposition of hippuryl-L-histidyl-L-leucine.. Chemical and Pharmaceutical Bulletin. 39(3). 761–764. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact